| Tag | Content |
|---|
EnhancerAtlas ID | HS177-06264 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr13:51170790-51171460 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr13:51171056-51171067 | TTTGACCTTGA | - | 6.14 | | Esrra | MA0592.2 | chr13:51171057-51171068 | TTGACCTTGAA | - | 6.14 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_25691 | chr13:51160795-51173957 | DND41 | | SE_58491 | chr13:51158878-51211823 | Ly1 | | SE_59436 | chr13:51166591-51174286 | Ly3 | | SE_61160 | chr13:51160570-51187686 | HBL1 | | SE_61819 | chr13:51160208-51175905 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I050592 | chr13 | 51166600 | 51170969 |
|
Enhancer Sequence | GGACTCCTAA CTTTTCATTT TCATATGGCT GCGGAGGGCA TGCCTAGCAT ATCTGTGGAA 60
CCAGGGTGCC TGTGGAGAAT GGATGCATAA TAAACGTTTG GACCATGGAG TGAAATAAGC 120
CAAATAGGGC ATAGCTTCAT AATTAAATTC ACAGATGAAA CCTGATGGAG ATAGGATCTG 180
GGAACACCAG CGACAATTGA GAAACTGCCC CAGAGGGATA GAGGGGAAAG GGACTAGCTG 240
TATAGGCAGG AAATAACAAC TTGAGGTTTG ACCTTGAACA ATGGAAGGCT AATTCACCTG 300
GGCTGACATA ATTGAAAACA CAGATATACA GCACAGAAAA GGCACATGGA AATGTAAACC 360
GTTGATAAGA GCTTGGGGAG AGTAAGTAGC AAATTGGATT GCAGATTAAA TCAGGGCAAG 420
GTTGCAAATT ACTCAACTCC AGTGAGGGGT CTGCTAGACT TACAGCCCTG CTTGGCTCCA 480
CTGTGAGCTG GTGCAGGCAA AGGAAAGGCT GGGACATCAT AAGATAGGGA CCCAGGGCTT 540
CTTCCTTCAC CAATGCACAG AGGAACACAG GCAAGAGCTA ATAGCAGGGA GGTCACTGAT 600
TGGTGTGGGC CTGTGTCTCT CTTGGCTTAA ATAAAGTGGG AAAGAACACT TTGCCTTACA 660
TGCAAGATCC 670
|
